Home LiteratureArticle Details
PMID: 2471771 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

T cell memory. Long-term persistence of virus-specific cytotoxic T cells.

The Journal of experimental medicine ·Vol. 169 ·No. 6 ·1989-06-01 ·Pages 1993-2005

Jamieson BD, Ahmed R

Abstract

This study documents that virus-specific CTL can persist indefinitely in vivo. This was accomplished by transferring Thy-1.1 T cells into Thy-1.2 recipient mice to specifically identify the donor T cell population and to characterize its antigenic specificity and function by using a virus-specific CTL assay. Thy-1.1+ T cells from mice previously immunized with lymphocytic choriomeningitis virus (LCMV) were transferred into Thy-1.2 mice persistently infected with LCMV. The transferred LCMV-specific CTL (Thy-1.1+ CD8+) eliminate virus from the chronically infected carriers and persist in the recipient mice in small numbers, comprising only a minor fraction of the total T cells. Upon re-exposure to virus, these long-lived "resting" CD8+ T cells proliferate in vivo to become the predominant cell population. These donor CD8+ T cells can be recovered up to a year post-transfer and still retain antigenic specificity and biological function. They kill LCMV infected H-2-matched cells in vitro and can eliminate virus upon transfer into a second infected host. In addition, these long-lived CD8+ T cells appear not to be dependent on help from CD4+ T cells, since depletion of CD4+ T cells has minimal or no effect on their biological properties (proliferation, CTL response, viral clearance). These donor CTL also exhibit an immunodominance over the host-derived LCMV-specific CTL response. When both host and donor T cells are present, the donor CTL response is dominant over the potential CTL response of the cured carrier host. Taken together, these results suggest that virus-specific CTL can persist for the life span of the host as memory cells.

MeSH Terms
Animals Antigens, Differentiation, T-Lymphocyte Antigens, Viral/immunology CD8 Antigens Cell Survival Cytotoxicity, Immunologic Epitopes/immunology Immunization, Passive Immunologic Memory Lymphocyte Activation Lymphocyte Depletion Lymphocytic Choriomeningitis/immunology,microbiology Lymphocytic choriomeningitis virus/growth & development,immunology Mice Mice, Inbred C57BL Phenotype Species Specificity T-Lymphocytes, Cytotoxic/classification,immunology,transplantation
Chemicals
Antigens, Differentiation, T-Lymphocyte Antigens, Viral CD8 Antigens Epitopes
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Jamieson B D
Department of Microbiology and Immunology, UCLA School of Medicine, Los Angeles, CA 90024.
Ahmed R
References (28)
28 references, click to expand
  1. Cytolytic T lymphocytes.
    Annu Rev Immunol. 1983;1:273-306 PMID: 6085785
  2. Both L3T4+ and Lyt-2+ helper T cells initiate cytotoxic T lymphocyte responses against allogenic major histocompatibility antigens but not against trinitrophenyl-modified self.
    J Exp Med. 1985 Aug 1;162(2):427-43 PMID: 3160804
  3. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.
    Cell. 1986 Mar 28;44(6):959-68 PMID: 2420472
  4. Antigen-driven long term-cultured T cells proliferate in vivo, distribute widely, mediate specific tumor therapy, and persist long-term as functional memory T cells.
    J Exp Med. 1986 May 1;163(5):1100-12 PMID: 3084700
  5. Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system.
    Nature. 1986 May 15-21;321(6067):239-43 PMID: 3086743
  6. Virus-lymphocyte interaction: T cells of the helper subset are infected with lymphocytic choriomeningitis virus during persistent infection in vivo.
    J Virol. 1987 May;61(5):1571-6 PMID: 2952807
  7. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2.
    Nature. 1987 Apr 30-May 6;326(6116):881-2 PMID: 2437457
  8. Use of synthetic peptides of influenza nucleoprotein to define epitopes recognized by class I-restricted cytotoxic T lymphocytes.
    J Exp Med. 1987 Jun 1;165(6):1508-23 PMID: 2438367
  9. CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity.
    J Virol. 1987 Oct;61(10):3102-8 PMID: 3041033
  10. Clearance of persistent respiratory syncytial virus infections in immunodeficient mice following transfer of primed T cells.
    Immunology. 1987 Sep;62(1):133-8 PMID: 3498683
  11. Immune therapy of a persistent and disseminated viral infection.
    J Virol. 1987 Dec;61(12):3920-9 PMID: 3682061
  12. Effective clearance of a persistent viral infection requires cooperation between virus-specific Lyt2+ T cells and nonspecific bone marrow-derived cells.
    J Virol. 1987 Dec;61(12):3930-7 PMID: 3500329
  13. T-cell tolerance: exposure to virus in utero does not cause a permanent deletion of specific T cells.
    Proc Natl Acad Sci U S A. 1988 Apr;85(7):2265-8 PMID: 3258424
  14. T4+ T helper cell function in vivo: differential requirement for induction of antiviral cytotoxic T-cell and antibody responses.
    J Virol. 1988 Jun;62(6):2102-6 PMID: 2966865
  15. Fine dissection of a nine amino acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virus-specific class I-restricted H-2Db cytotoxic T lymphocytes.
    J Exp Med. 1988 Aug 1;168(2):559-70 PMID: 2457647
  16. Role of lymphokine-secreting CD8+ T cells in cytotoxic T lymphocyte responses against vaccinia virus.
    J Immunol. 1989 Jan 1;142(1):270-3 PMID: 2521235
  17. The activation of IL-2 transcription in L3T4+ and Lyt-2+ lymphocytes during virus infection in vivo.
    J Immunol. 1989 Feb 15;142(4):1287-92 PMID: 2783708
  18. STUDIES ON IMMUNOLOGICAL TOLERANCE TO LCM VIRUS. 2. TREATMENT OF VIRUS CARRIER MICE BY ADOPTIVE IMMUNIZATION.
    Acta Pathol Microbiol Scand. 1963;57:465-87 PMID: 14062322
  19. H-2 compatibility requirement for virus-specific T cell-mediated effector functions in vivo. I. Specificity of T cells conferring antiviral protection against lymphocytic choriomeningitis virus is associated with H-2K and H-2D.
    J Immunol. 1976 Nov;117(5 Pt 1):1495-502 PMID: 794412
  20. MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.
    Adv Immunol. 1979;27:51-177 PMID: 92183
  21. Induction, control and consequences of virus specific cytotoxic T cells.
    Immunol Rev. 1981;58:157-80 PMID: 6796496
  22. Protection of mice from fatal herpes simplex virus type 1 infection by adoptive transfer of cloned virus-specific and H-2-restricted cytotoxic T lymphocytes.
    J Gen Virol. 1983 Feb;64 (Pt 2):443-7 PMID: 6601180
  23. Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5: expression of L3T4a by functional T cell clones appears to correlate primarily with class II MHC antigen-reactivity.
    Immunol Rev. 1983;74:29-56 PMID: 6195085
  24. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence.
    J Exp Med. 1984 Aug 1;160(2):521-40 PMID: 6332167
  25. In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific.
    J Exp Med. 1984 Sep 1;160(3):814-26 PMID: 6206190
  26. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo.
    J Virol. 1984 Sep;51(3):682-6 PMID: 6332201
  27. Resting and sensitized T lymphocytes exhibit distinct stimulatory (antigen-presenting cell) requirements for growth and lymphokine release.
    J Exp Med. 1984 Dec 1;160(6):1717-35 PMID: 6239901
  28. Differences in antigen presentation to MHC class I-and class II-restricted influenza virus-specific cytolytic T lymphocyte clones.
    J Exp Med. 1986 Apr 1;163(4):903-21 PMID: 3485173
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1989-06-01
Pages
1993-2005
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2189353
Subset
IM
Grants
NINDS NIH HHS · NS-21496 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]